Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Plankton Australia is a marine biotechnology company specializing in the cultivation and production of high-quality marine phytoplankton for human nutrition. The company's flagship product, Ultana Phytoplankton, is a multi-strain blend of microscopic algae that provides a concentrated source of essential nutrients, including Omega-3 EPA, phospholipids, and antioxidants. Their production process utilizes controlled, closed-loop systems to ensure purity and sustainability, avoiding environmental contaminants. Plankton Australia serves the global health and wellness market by providing plant-based, nutrient-dense alternatives to traditional fish-derived supplements.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Plankton Australia.